Published in Clin Biochem on March 01, 2005
Ochratoxin A: in utero exposure in mice induces adducts in testicular DNA. Toxins (Basel) (2010) 1.01
Cytochrome P450 1A2 detoxicates aristolochic acid in the mouse. Drug Metab Dispos (2010) 0.97
Balkan endemic nephropathy-current status and future perspectives. Clin Kidney J (2013) 0.91
Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2. Toxicol Sci (2011) 0.88
«Suspects» in etiology of endemic nephropathy: aristolochic acid versus mycotoxins. Toxins (Basel) (2010) 0.80
Genetic loci that affect aristolochic acid-induced nephrotoxicity in the mouse. Am J Physiol Renal Physiol (2011) 0.77
Association of a bitter taste receptor mutation with Balkan Endemic Nephropathy (BEN). BMC Med Genet (2012) 0.77
Limitations and plausibility of the Pliocene lignite hypothesis in explaining the etiology of Balkan endemic nephropathy. Int J Occup Environ Health (2014) 0.76
Organic compounds in water extracts of coal: links to Balkan endemic nephropathy. Environ Geochem Health (2013) 0.76
Is increased susceptibility to Balkan endemic nephropathy in carriers of common GSTA1 (*A/*B) polymorphism linked with the catalytic role of GSTA1 in ochratoxin a biotransformation? Serbian case control study and in silico analysis. Toxins (Basel) (2014) 0.75
Balkan endemic nephropathy: an update on its aetiology. Arch Toxicol (2016) 0.75
Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype-phenotype in a Caucasian population. Clin Chem (2005) 1.96
Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit (2009) 1.68
Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia. Dement Geriatr Cogn Disord (2006) 1.49
cDNA microarray analysis reveals new candidate genes possibly linked to side effects under mycophenolate mofetil therapy. Transplantation (2004) 1.48
Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury. Clin Chem (2013) 1.48
Differences in nucleotide hydrolysis contribute to the differences between erythrocyte 6-thioguanine nucleotide concentrations determined by two widely used methods. Clin Chem (2003) 1.45
Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis. J Neurol Neurosurg Psychiatry (2012) 1.41
The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy. J Am Soc Nephrol (2002) 1.38
Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial. Transplantation (2008) 1.34
Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal. Nephrol Dial Transplant (2007) 1.30
Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Ther Drug Monit (2006) 1.30
Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. Clin Chem (2002) 1.23
Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in exon 6. Ther Drug Monit (2007) 1.17
Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus. Clin Chem (2005) 1.14
Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J Hum Genet (2009) 1.08
Acyl glucuronide drug metabolites: toxicological and analytical implications. Ther Drug Monit (2003) 1.08
Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea. Transplantation (2003) 1.06
Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers. J Hepatol (2002) 1.04
Proteome of conidial surface associated proteins of Aspergillus fumigatus reflecting potential vaccine candidates and allergens. J Proteome Res (2006) 1.04
AmpliChip CYP450 GeneChip: a new gene chip that allows rapid and accurate CYP2D6 genotyping. Ther Drug Monit (2006) 1.04
Cognitive impairment and dementia in elderly people living in rural Benin, west Africa. Dement Geriatr Cogn Disord (2009) 1.02
Influencing factors of dsDNA dye (high-resolution) melting curves and improved genotype call based on thermodynamic considerations. Anal Biochem (2008) 1.01
In vitro gender differences in neuronal survival on hypoxia and in 17beta-estradiol-mediated neuroprotection. J Cereb Blood Flow Metab (2005) 1.01
MODULAR ANALYTICS: A New Approach to Automation in the Clinical Laboratory. J Autom Methods Manag Chem (2005) 1.00
Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. Clin Chem (2007) 0.99
N-acetylcysteine decreases lactate signal intensities in liver tissue and improves liver function in septic shock patients, as shown by magnetic resonance spectroscopy: extended case report. Crit Care (2004) 0.98
Proteins identified as targets of the acyl glucuronide metabolite of mycophenolic acid in kidney tissue from mycophenolate mofetil treated rats. Biochimie (2006) 0.97
Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study. Clin Chem (2005) 0.97
Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer. Clin Biochem (2008) 0.97
Gene-specific fluorescence in-situ hybridization analysis on tissue microarray to refine the region of chromosome 20q amplification in melanoma. Melanoma Res (2007) 0.96
Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. Obesity (Silver Spring) (2013) 0.96
Profile of chromosomal aberrations in different gestational age spontaneous abortions detected by comparative genomic hybridization. Eur J Obstet Gynecol Reprod Biol (2006) 0.96
Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients. Ther Drug Monit (2002) 0.95
Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability. Expert Opin Drug Metab Toxicol (2005) 0.94
High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol (2003) 0.94
Pharmacokinetics of mycophenolate mofetil in hematopoietic stem cell transplant recipients. Ther Drug Monit (2007) 0.94
Analytic aspects of monitoring therapy with thiopurine medications. Ther Drug Monit (2004) 0.93
Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy. J Nephrol (2004) 0.93
Identification of protein targets for mycophenolic acid acyl glucuronide in rat liver and colon tissue. Proteomics (2004) 0.93
Identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach. PLoS One (2013) 0.92
Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients. Clin Pharmacol Ther (2006) 0.91
Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1. Diabetes (2009) 0.90
Immuno-reactive molecules identified from the secreted proteome of Aspergillus fumigatus. J Proteome Res (2010) 0.90
Biomarkers as a tool for management of immunosuppression in transplant patients. Ther Drug Monit (2010) 0.90
Development of the first marmoset-specific DNA microarray (EUMAMA): a new genetic tool for large-scale expression profiling in a non-human primate. BMC Genomics (2007) 0.89
Pharmacogenetic screening for drug therapy: from single gene markers to decision making in the next generation sequencing era. Pathology (2012) 0.88
An open prospective pilot study on the use of rapamycin after penetrating high-risk keratoplasty. Transplantation (2006) 0.87
Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia. Clin Biochem (2004) 0.87
Liquid chromatography-tandem mass spectrometry or automated immunoassays: what are the future trends in therapeutic drug monitoring? Clin Chem (2012) 0.87
International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology working group on immunosuppressive drug monitoring. Ther Drug Monit (2002) 0.87
Proteomics approach to identify the interacting partners of cellular prion protein and characterization of Rab7a interaction in neuronal cells. J Proteome Res (2011) 0.86
Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation. Ther Drug Monit (2016) 0.86
Pre-analytical effects of different lithium heparin plasma separation tubes in the routine clinical chemistry laboratory. Clin Chem Lab Med (2011) 0.85
Pharmacokinetics of meropenem in critically ill patients with severe infections. Ther Drug Monit (2013) 0.85
Extracellular Toxoplasma gondii tachyzoites do not require carbon source uptake for ATP maintenance, gliding motility and invasion in the first hour of their extracellular life. Int J Parasitol (2011) 0.84
No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients. J Cancer Res Clin Oncol (2007) 0.84
Clinical utility of a new enzymatic assay for determination of mycophenolic acid in comparison with an optimized LC-MS/MS method. Ther Drug Monit (2009) 0.84
Physiological role of the cellular prion protein (PrPc): protein profiling study in two cell culture systems. J Proteome Res (2008) 0.84
Long-term pharmacokinetics of mycophenolic acid in pediatric renal transplant recipients over 3 years posttransplant. Ther Drug Monit (2008) 0.84
NAT2*5/*5 genotype (341T>C) is a potential risk factor for schistosomiasis-associated bladder cancer in Egyptians. Ther Drug Monit (2005) 0.83
Thrombopoietin inhibits nerve growth factor-induced neuronal differentiation and ERK signalling. Cell Signal (2007) 0.83
Pharmacokinetics and safety of lidocaine and monoethylglycinexylidide in liposuction: a microdialysis study. Plast Reconstr Surg (2004) 0.83
Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer's disease patients. J Neurochem (2012) 0.83
Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients. Clin Biochem (2004) 0.82
Differential proteome analysis of human embryonic kidney cell line (HEK-293) following mycophenolic acid treatment. Proteome Sci (2011) 0.82
Characterization of the inosine triphosphatase (ITPA) gene: haplotype structure, haplotype-phenotype correlation and promoter function. Ther Drug Monit (2008) 0.82
Two for typing: homogeneous combined single-nucleotide polymorphism scanning and genotyping. Clin Chem (2005) 0.82
CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess. Int J Mol Epidemiol Genet (2010) 0.82